Author:
Kassner Ursula,Hebes Sylvia,Steinhagen-Thiessen Elisabeth
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Dietel, M., A.S. Fauci, and Charité — Universitätsmedizin (Berlin), Harrisons Innere Medizin. 17. Aufl., Sonderausg. ed. 2009, Berlin: ABW Wissenschaftsverlag. 2 Bände (3419 S.), 1 Register.
2. Watts, G.F., I. Hamilton-Craig, and D.R. Sullivan, NICE guidance on familial hypercholesterolaemia: all sugar and spice? Heart Lung Circ, 2009. 18(3): p. 181–183.
3. Aarden, E., I. Van Hoyweghen, and K. Horstman, The paradox of public health genomics: definition and diagnosis of familial hypercholesterolaemia in three European countries. Scand J Public Health, 2011. 39(6): p. 634–639.
4. Huijgen, R., et al., Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl Levels. Hum Mutat, 2012. 33(2): p. 448–455.
5. Humphries, S.E., Guidelines for the identification and management of patients with familial hypercholesterolaemia (FH): are we coming to a consensus? Atheroscler Suppl, 2011. 12(2): p. 217–220.